Gene Knockout Shows That PML (TRIM19) Does Not Restrict the Early Stages of HIV-1 Infection in Human Cell Lines

Gene Knockout Shows That PML (TRIM19) Does Not Restrict the Early Stages of HIV-1 Infection in Human Cell Lines

Bibliographic Details
Main Authors:	Nasser Masroori, Pearl Cherry, Natacha Merindol, Jia-xin Li, Caroline Dufour, Lina Poulain, Mélodie B. Plourde, Lionel Berthoux, Carolyn B. Coyne, Christopher Aiken, Beatriz Pacheco
Format:	Article
Language:	English
Published:	American Society for Microbiology 2017-06-01
Series:	mSphere

Similar Items

Editing of the human TRIM5 gene to introduce mutations with the potential to inhibit HIV-1.
by: Caroline Dufour, et al.
Published: (2018-01-01)

HIV-1 capsids from B27/B57+ elite controllers escape Mx2 but are targeted by TRIM5α, leading to the induction of an antiviral state.
by: Natacha Merindol, et al.
Published: (2018-11-01)

Editing of the TRIM5 Gene Decreases the Permissiveness of Human T Lymphocytic Cells to HIV-1
by: Kevin Désaulniers, et al.
Published: (2021-12-01)

Editing of the Human <i>TRIM5</i> Gene Decreases the Permissiveness of Jurkat T Lymphocytic Cells to HIV-1
by: Kevin Désaulniers, et al.
Published: (2020-06-01)

Étude du rôle de PML dans la restriction des rétrovirus
by: Masroori, Nasser
Published: (2017)

TRIM19/PML Restricts HIV Infection in a Cell Type-Dependent Manner
by: Tanja Kahle, et al.
Published: (2015-12-01)

PML/TRIM19-Dependent Inhibition of Retroviral Reverse-Transcription by Daxx.
by: Jacques Dutrieux, et al.
Published: (2015-11-01)

A putative SUMO interacting motif in the B30.2/SPRY domain of rhesus macaque TRIM5α important for NF-κB/AP-1 signaling and HIV-1 restriction
by: Marie-Édith Nepveu-Traversy, et al.
Published: (2016-01-01)

TRIM5α and TRIMCyp form apparent hexamers and their multimeric state is not affected by exposure to restriction-sensitive viruses or by treatment with pharmacological inhibitors
by: Berthoux Lionel, et al.
Published: (2009-11-01)

Both TRIM5α and TRIMCyp have only weak antiviral activity in canine D17 cells
by: Berthoux Lionel, et al.
Published: (2007-09-01)

Proteasomal degradation of TRIM5alpha during retrovirus restriction.
by: Christopher James Rold, et al.
Published: (2008-05-01)

PML degradation: multiple ways to eliminate PML.
by: Andrea eRabellino, et al.
Published: (2013-03-01)

Controlling senescence by PML and PML nuclear bodies
by: Acevedo Aquino, Mariana de la Cruz
Published: (2017)

Crystal structure of cytomegalovirus IE1 protein reveals targeting of TRIM family member PML via coiled-coil interactions.
by: Myriam Scherer, et al.
Published: (2014-11-01)

The role of PML and PML nuclear bodies in FADD-mediated apoptosis
by: Jensen, Kirsten Ellerup
Published: (2014)

Specificity of PML and PML-RARα SUMO modification in recruiting Daxx
by: Nai-Jia Huang, et al.
Published: (2008)

PML Bodies in Mitosis
by: Anna Lång, et al.
Published: (2019-08-01)

PML, SUMOylation and senescence
by: Hugues eDe Thé, et al.
Published: (2013-07-01)

Circadian behavior of mice deficient in PER1/PML or PER2/PML
by: Takao Miki, et al.
Published: (2013-08-01)

Étude du rôle des lymphocytes T chez les receveurs pédiatriques de greffe de sang de cordon ombilical
by: Merindol, Natacha
Published: (2011)

Étude du rôle des lymphocytes T chez les receveurs pédiatriques de greffe de sang de cordon ombilical
by: Merindol, Natacha
Published: (2011)

Expression and function of PML-RARA in the hematopoietic progenitor cells of Ctsg-PML-RARA mice.
by: Lukas D Wartman, et al.
Published: (2012-01-01)

Étude des protéines angiomotine et angiomotine-like1
by: Plourde, Mélodie B.
Published: (2009)

Étude des protéines angiomotine et angiomotine-like1
by: B. Plourde, Mélodie
Published: (2009)

Cyclophilin A potentiates TRIM5α inhibition of HIV-1 nuclear import without promoting TRIM5α binding to the viral capsid.
by: Mallori Burse, et al.
Published: (2017-01-01)

Is PML a tumor suppressor?
by: Massimiliano eMazza, et al.
Published: (2013-07-01)

Differential roles of PML isoforms
by: Sébastien eNisole, et al.
Published: (2013-05-01)

The role of the PML ring finger
by: Pedersen, Eva Wessel
Published: (2005)

The DNA binding property of PML/RARA but not the integrity of PML nuclear bodies is indispensable for leukemic transformation.
by: Xi Liu, et al.
Published: (2014-01-01)

Tripartite Motif-Containing Protein 22 Interacts with Class II Transactivator and Orchestrates Its Recruitment in Nuclear Bodies Containing TRIM19/PML and Cyclin T1
by: Greta Forlani, et al.
Published: (2017-05-01)

Pathologic Findings of Chronic PML-IRIS in a Patient with Prolonged PML Survival Following Natalizumab Treatment
by: Mai Himedan MD, et al.
Published: (2017-09-01)

Emerging cellular functions of cytoplasmic PML
by: Guoxiang eJin, et al.
Published: (2013-06-01)

The role of PML ubiquitination in human malignancies
by: Chen Ruey-Hwa, et al.
Published: (2012-08-01)

PML: Not all about tumor suppression
by: Natalia eMartin-Martin, et al.
Published: (2013-08-01)

Multiblock Implementation of PML for the Wave Equation
by: Arafeh, Khairi
Published: (2010)

PML in the brain: from development to degeneration
by: Erica eKorb, et al.
Published: (2013-09-01)

The Role of PML in T cell Activation and Apoptosis
by: Wan-ni Yu, et al.
Published: (2002)

Characterization of the degron of KLHL20 on PML
by: Tzu-Yin Chen, et al.
Published: (2011)

Treatment of natalizumab‐associated PML with filgrastim
by: Dusan Stefoski, et al.
Published: (2019-05-01)

Requirement of PML SUMO interacting motif for RNF4- or arsenic trioxide-induced degradation of nuclear PML isoforms.
by: Mohamed Ali Maroui, et al.
Published: (2012-01-01)